Newsfeeds - Spark Newswire

1 minute read

Respiratory Infections Led OrthoPediatrics Miss Quarterly Sales Expectations, Analyst Calls It Transitory Issue

Today, 1:26 PM

Monday, OrthoPediatrics Corp (NASDAQ:KIDS) preannounced 4Q22 revenue of $31.0 million (up 25%), which was below the consensus of $33.2 million. The company…

KIDS

2 minute read

Analyst Ratings

Analyst Expectations for OrthoPediatrics’s Future

By Benzinga Insights

Today, 1:26 PM

Analysts have provided the following ratings for OrthoPediatrics (NASDAQ:KIDS) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

KIDS

19 minute read

Options

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 1:26 PM

Tuesday's session saw 325 companies set new 52-week lows.

AAPL

1 minute read

JMP Securities Maintains Market Outperform on OrthoPediatrics, Lowers Price Target to $60

By Benzinga Newsdesk

Today, 1:26 PM

JMP Securities analyst David Turkaly maintains OrthoPediatrics (NASDAQ:KIDS) with a Market Outperform and lowers the price target from $70 to $60.

KIDS

1 minute read

Needham Maintains Buy on OrthoPediatrics, Lowers Price Target to $50

By Benzinga Newsdesk

Today, 1:26 PM

Needham analyst Mike Matson maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and lowers the price target from $59 to $50.

KIDS

1 minute read

Earnings

Recap: OrthoPediatrics Q2 Earnings

By Benzinga Insights

Today, 1:26 PM

OrthoPediatrics (NASDAQ:KIDS) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

KIDS

1 minute read

Needham Maintains Buy on OrthoPediatrics, Lowers Price Target to $59

By Benzinga Newsdesk

Today, 1:26 PM

Needham analyst Mike Matson maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and lowers the price target from $65 to $59.

KIDS

1 minute read

OrthoPediatrics Q1 EPS $(0.30) Beats $(0.37) Estimate, Sales $23.42M Beat $22.75M Estimate

By Benzinga Newsdesk

Today, 1:26 PM

OrthoPediatrics (NASDAQ:KIDS) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.37) by 18.92 percent. This is a 20 percent decrease over losses of $(0.25) per share from the

KIDS

27 minute read

Earnings Scheduled For May 4, 2022

By Benzinga Insights

Today, 1:26 PM

Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.

ABC

1 minute read

OrthoPediatrics Q4 Sales $24.80M Beat $24.71M Estimate

By Benzinga Newsdesk

Today, 1:26 PM

OrthoPediatrics (NASDAQ:KIDS) reported quarterly sales of $24.80 million which beat the analyst consensus estimate of $24.71 million by 0.36 percent. This is a 31.05 percent increase over sales of $18.92 million the

KIDS